Charles A. Deignan, Chief Financial Officer at Clearside Biomedical, Inc. (CLSD), bought 10,000 shares at $1.36 ($14K) on 2019-03-15, disclosed to the SEC on 2019-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CLSD | SELL | 2022-01-20 | $18K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $18K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $13K | — | Filing → |